Coronavirus: Drugs

(asked on 31st March 2022) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the implications for its policies of reports of clinically vulnerable, clinically extremely vulnerable and immunosuppressed people experiencing challenges in accessing antiviral or retroviral treatments.


Answered by
Maggie Throup Portrait
Maggie Throup
This question was answered on 20th April 2022

The National Health Service is aware of some local issues and continues to support general practitioners, NHS 111 and hospital specialists to assist eligible patients to access an urgent assessment for these treatments by COVID-19 Medicine Delivery Units (CMDUs). All CMDUs have arrangements for treating patients at weekends. The Department continues to work with NHS England and NHS Improvement to improve patients’ access to COVID-19 treatments.

Reticulating Splines